All 1 tracked stories fall under one category: defense-tech. Of the tracked stories, 1 of 1 also mention Castellan, the most common co-covered peer. We currently track 1 Cross-Sector story that mention Vitruvian Medical, all published on March 13, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Vitruvian Medical
All 1 tracked stories fall under one category: defense-tech. Of the tracked stories, 1 of 1 also mention Castellan, the most common co-covered peer. We currently track 1 Cross-Sector story that mention Vitruvian Medical, all published on March 13, 2026. Each carries 2 original sources on average.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Vitruvian Medical. Shared-story counts are live from our verified record — not editorial picks.
Castellan has secured new funding to pioneer a franchised model for precision defense manufacturing, aiming to decentralize the production of critical components. This strategic shift addresses chronic supply chain vulnerabilities in the U.S. and European defense-industrial bases by empowering small-scale manufacturers.